Onyx Pharmaceuticals International GmbH
Company Overview
Management
Christopher McKinlay
Meggen
Member of the executive board
Individual signing authority
Christiaan Van den Broucke
Walchwil
Chairperson of the management board
Individual signing authority
Mary Lehmann
Moorpark, US
Having right to sign
Joint signing authority (any two to sign)
Amgen (Europe) GmbH
Zug
Llc member
Michael Aepli
Baar
Member of the executive board
Individual signing authority
Laura Brege
Portola Valley
Member of the executive board
Joint signing authority (any two to sign)
Dr. Juergen Lasowski
San Rafael
Joint signing authority (any two to sign)
Warren DeSouza
Oakland
Member of the executive board
Joint signing authority (any two to sign)
Onyx Pharmaceuticals, Inc.
Delaware
Llc member
Christoph Bölling
Küssnacht SZ
Having right to sign
Joint signing authority (any two to sign)
Onyx Pharmaceuticals (Luxembourg) S.à r.l.
Luxembourg (LU)
Llc member
Helen Torley
Palos Verdes Estates
Member of the executive board
Joint signing authority (any two to sign)
Luigi Costa
Le Vésinet (FR)
Member of the executive board
Individual signing authority
Luigi Costa
Thalwil
Member of the executive board
Individual signing authority
Matthew Fust
San Francisco (US)
Member of the executive board
Joint signing authority (any two to sign)
Frank Thiel
Bettwil
Chairperson of the management board
Individual signing authority
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 7030 | 11.06.2015 | 113 | 16.06.2015 | 2209579 |
| 2 | 13807 | 17.10.2014 | 204 | 22.10.2014 | 1782107 |
| 3 | 2990 | 03.03.2014 | 45 | 06.03.2014 | 1383901 |
| 4 | 15043 | 11.11.2013 | 221 | 14.11.2013 | 1180529 |
| 5 | 8747 | 27.06.2013 | 125 | 02.07.2013 | 951295 |
| 6 | 5309 | 18.04.2013 | 77 | 23.04.2013 | 7160242 |
| 7 | 7480 | 13.06.2012 | 116 | 18.06.2012 | 6722260 |
| 8 | 3176 | 06.03.2012 | 49 | 09.03.2012 | 6587176 |
| 9 | 12814 | 23.09.2011 | 188 | 28.09.2011 | 6352788 |
| 10 | 3382 | 08.03.2011 | 50 | 11.03.2011 | 6071700 |
Company Purpose
Forschung, Entwicklung, Vertrieb und Verkauf von Technologien und pharmazeutischen Produkten, insbesondere die Verwaltung der Entwicklung und kommerziellen Aktivitäten von Onyx in Europa, Verwaltung des klinischen und kommerziellen Produktangebots in Europa und in anderen Regionen der Welt, Verwaltung des geistigen Eigentums von Onyx in Europa und in anderen Gebieten, Verwaltung von Partnerschaften und Joint Ventures, Führung von allgemeinen und administrativenAktivitäten wie beispielsweise Finanzen und Personal; vollständige Zweckumschreibung gemäss Statuten